# Alight, Inc. / Delaware: financial statements, quarterly ALIT · NYSE · CIK 1809104 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/alit.md) · [Financials](/companies/alit/financials.md) · [Filings](/companies/alit/filings.md) · [Insiders](/companies/alit/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/alit/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [557](/filings/0001809104-24-000029.md) | [682 d](/filings/0001628280-26-011108.md) | [559](/filings/0001809104-25-000175.md) | [538](/filings/0001628280-25-037820.md) | [555](/filings/0001628280-25-049916.md) | [680 d](/filings/0001628280-26-011108.md) | [548](/filings/0001628280-26-030596.md) | [528](/filings/0001628280-26-052636.md) | [533](/filings/0001628280-25-049916.md) | [653 d](/filings/0001628280-26-011108.md) | [534](/filings/0001628280-26-030596.md) | [511](/filings/0001628280-26-052636.md) | | Gross profit | $m | [166](/filings/0001809104-24-000029.md) | [270 d](/filings/0001628280-26-011108.md) | [182](/filings/0001809104-25-000175.md) | [167](/filings/0001628280-25-037820.md) | [174](/filings/0001628280-25-049916.md) | [271 d](/filings/0001628280-26-011108.md) | [171](/filings/0001628280-26-030596.md) | [176](/filings/0001628280-26-052636.md) | [178](/filings/0001628280-25-049916.md) | [240 d](/filings/0001628280-26-011108.md) | [156](/filings/0001628280-26-030596.md) | [142](/filings/0001628280-26-052636.md) | | Selling, general and administrative | $m | [136](/filings/0001809104-24-000029.md) | [154 d](/filings/0001628280-26-011108.md) | [146](/filings/0001809104-25-000175.md) | [146](/filings/0001628280-25-037820.md) | [142](/filings/0001628280-25-049916.md) | [151 d](/filings/0001628280-26-011108.md) | [104](/filings/0001628280-26-030596.md) | [130](/filings/0001628280-26-052636.md) | [87.0](/filings/0001628280-25-049916.md) | [114 d](/filings/0001628280-26-011108.md) | [105](/filings/0001628280-26-030596.md) | [109](/filings/0001628280-26-052636.md) | | Operating income | $m | [(45.0)](/filings/0001809104-24-000029.md) | [40.0 d](/filings/0001628280-26-011108.md) | [(40.0)](/filings/0001809104-25-000175.md) | [(52.0)](/filings/0001628280-25-037820.md) | [(42.0)](/filings/0001628280-25-049916.md) | [44.0 d](/filings/0001628280-26-011108.md) | [(8.0)](/filings/0001628280-26-030596.md) | [(1,010)](/filings/0001628280-26-052636.md) | [(1,322)](/filings/0001628280-25-049916.md) | [(750) d](/filings/0001628280-26-011108.md) | [(22.0)](/filings/0001628280-26-030596.md) | [(40.0)](/filings/0001628280-26-052636.md) | | Interest expense | $m | [34.0](/filings/0001809104-24-000029.md) | [31.0 d](/filings/0000950170-24-022978.md) | [31.0](/filings/0000950170-24-055909.md) | [33.0](/filings/0001809104-24-000015.md) | [19.0](/filings/0001809104-24-000029.md) | [20.0 d](/filings/0001628280-26-011108.md) | [22.0](/filings/0001628280-26-030596.md) | [22.0](/filings/0001628280-26-052636.md) | [24.0](/filings/0001628280-25-049916.md) | [24.0 d](/filings/0001628280-26-011108.md) | [24.0](/filings/0001628280-26-030596.md) | [24.0](/filings/0001628280-26-052636.md) | | Income tax | $m | [(14.0)](/filings/0001809104-24-000029.md) | [25.0 d](/filings/0001628280-26-011108.md) | [(27.0)](/filings/0001809104-25-000175.md) | [2.0](/filings/0001628280-25-037820.md) | [(9.0)](/filings/0001628280-25-049916.md) | [26.0 d](/filings/0001628280-26-011108.md) | [(3.0)](/filings/0001628280-26-030596.md) | [(3.0)](/filings/0001628280-26-052636.md) | [(198)](/filings/0001628280-25-049916.md) | [220 d](/filings/0001628280-26-011108.md) | [(7.0)](/filings/0001628280-26-030596.md) | [(9.0)](/filings/0001628280-26-052636.md) | | Net income | $m | [(48.0)](/filings/0001809104-24-000029.md) | [(162) d](/filings/0001628280-26-011108.md) | [(114)](/filings/0001809104-25-000175.md) | [23.0](/filings/0001628280-25-037820.md) | [(74.0)](/filings/0001628280-25-049916.md) | [8.0 d](/filings/0001628280-26-011108.md) | [(25.0)](/filings/0001628280-26-030596.md) | [(1,073)](/filings/0001628280-26-052636.md) | [(1,067)](/filings/0001628280-25-049916.md) | [(932) d](/filings/0001628280-26-011108.md) | [(19.0)](/filings/0001628280-26-030596.md) | [(10.0)](/filings/0001628280-26-052636.md) | | Diluted EPS | $ per share | [(0.10)](/filings/0001809104-24-000029.md) | not reported | [(0.21)](/filings/0001809104-25-000175.md) | [0.04](/filings/0001628280-25-037820.md) | [(0.14)](/filings/0001628280-25-049916.md) | not reported | [(0.05)](/filings/0001628280-26-030596.md) | [(40.61)](/filings/0001628280-26-052636.md) | [(2.02)](/filings/0001628280-25-049916.md) | not reported | [(0.04)](/filings/0001628280-26-030596.md) | [(0.38)](/filings/0001628280-26-052636.md) | | Basic EPS | $ per share | [(0.10)](/filings/0001809104-24-000029.md) | not reported | [(0.21)](/filings/0001809104-25-000175.md) | [0.04](/filings/0001628280-25-037820.md) | [(0.14)](/filings/0001628280-25-049916.md) | not reported | [(0.05)](/filings/0001628280-26-030596.md) | [(40.61)](/filings/0001628280-26-052636.md) | [(2.02)](/filings/0001628280-25-049916.md) | not reported | [(0.04)](/filings/0001628280-26-030596.md) | [(0.38)](/filings/0001628280-26-052636.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [0.3](/filings/0001809104-24-000029.md) | [0.3](/filings/0001628280-26-011108.md) | [0.3](/filings/0001809104-25-000175.md) | [0.2](/filings/0001628280-25-037820.md) | [0.3](/filings/0001628280-25-049916.md) | [0.3](/filings/0001628280-26-011108.md) | [0.2](/filings/0001628280-26-030596.md) | [0.2](/filings/0001628280-26-052636.md) | [0.2](/filings/0001628280-25-049916.md) | [0.3](/filings/0001628280-26-052636.md) | [0.2](/filings/0001628280-26-030596.md) | [0.2](/filings/0001628280-26-052636.md) | | Current assets | $bn | [2.5](/filings/0000950170-23-057516.md) | [2.8](/filings/0001809104-25-000062.md) | [3.6](/filings/0000950170-24-055909.md) | [3.4](/filings/0001809104-24-000015.md) | [1.2](/filings/0001809104-24-000029.md) | [1.3](/filings/0001628280-26-011108.md) | [1.1](/filings/0001809104-25-000175.md) | [1.0](/filings/0001628280-25-037820.md) | [1.0](/filings/0001628280-25-049916.md) | [1.1](/filings/0001628280-26-052636.md) | [1.0](/filings/0001628280-26-030596.md) | [1.0](/filings/0001628280-26-052636.md) | | Total assets | $bn | [10.7](/filings/0000950170-23-057516.md) | [10.8](/filings/0001809104-25-000062.md) | [10.7](/filings/0000950170-24-055909.md) | [10.5](/filings/0001809104-24-000015.md) | [8.3](/filings/0001809104-24-000029.md) | [8.2](/filings/0001628280-26-011108.md) | [7.9](/filings/0001809104-25-000175.md) | [6.8](/filings/0001628280-25-037820.md) | [5.5](/filings/0001628280-25-049916.md) | [4.6](/filings/0001628280-26-052636.md) | [4.3](/filings/0001628280-26-030596.md) | [4.3](/filings/0001628280-26-052636.md) | | Current liabilities | $bn | [2.1](/filings/0000950170-23-057516.md) | [2.2](/filings/0001809104-25-000062.md) | [2.3](/filings/0000950170-24-055909.md) | [2.5](/filings/0001809104-24-000015.md) | [0.9](/filings/0001809104-24-000029.md) | [0.9](/filings/0001628280-26-011108.md) | [0.9](/filings/0001809104-25-000175.md) | [0.9](/filings/0001628280-25-037820.md) | [0.8](/filings/0001628280-25-049916.md) | [0.9](/filings/0001628280-26-052636.md) | [0.7](/filings/0001628280-26-030596.md) | [0.7](/filings/0001628280-26-052636.md) | | Total liabilities | $bn | [5.9](/filings/0000950170-23-057516.md) | [6.0](/filings/0001809104-25-000062.md) | [6.2](/filings/0000950170-24-055909.md) | [6.0](/filings/0001809104-24-000015.md) | [3.9](/filings/0001809104-24-000029.md) | [3.9](/filings/0001628280-26-011108.md) | [3.7](/filings/0001809104-25-000175.md) | [3.7](/filings/0001628280-25-037820.md) | [3.5](/filings/0001628280-25-049916.md) | [3.5](/filings/0001628280-26-052636.md) | [3.3](/filings/0001628280-26-030596.md) | [3.2](/filings/0001628280-26-052636.md) | | Long-term debt | $bn | [2.8](/filings/0000950170-23-057516.md) | [2.8](/filings/0001809104-25-000062.md) | [2.8](/filings/0000950170-24-055909.md) | [2.5](/filings/0001809104-24-000015.md) | [2.0](/filings/0001809104-24-000029.md) | [2.0](/filings/0001628280-26-011108.md) | [2.0](/filings/0001809104-25-000175.md) | [2.0](/filings/0001628280-25-037820.md) | [2.0](/filings/0001628280-25-049916.md) | [2.0](/filings/0001628280-26-052636.md) | [2.0](/filings/0001628280-26-030596.md) | [2.0](/filings/0001628280-26-052636.md) | | Current portion of debt | $bn | [0.0](/filings/0000950170-23-057516.md) | [0.0](/filings/0001809104-25-000062.md) | [0.0](/filings/0000950170-24-055909.md) | [0.3](/filings/0001809104-24-000015.md) | [0.0](/filings/0001809104-24-000029.md) | [0.0](/filings/0001628280-26-011108.md) | [0.0](/filings/0001809104-25-000175.md) | [0.0](/filings/0001628280-25-037820.md) | [0.0](/filings/0001628280-25-049916.md) | [0.0](/filings/0001628280-26-052636.md) | [0.0](/filings/0001628280-26-030596.md) | [0.0](/filings/0001628280-26-052636.md) | | Shareholders' equity | $bn | [4.5](/filings/0000950170-23-057516.md) | [4.5](/filings/0001809104-25-000062.md) | [4.5](/filings/0000950170-24-055909.md) | [4.5](/filings/0001809104-24-000015.md) | [4.3](/filings/0001809104-24-000029.md) | [4.3](/filings/0001628280-26-011108.md) | [4.2](/filings/0001809104-25-000175.md) | [3.1](/filings/0001628280-25-037820.md) | [2.0](/filings/0001628280-25-049916.md) | [1.0](/filings/0001628280-26-052636.md) | [1.0](/filings/0001628280-26-030596.md) | [1.0](/filings/0001628280-26-052636.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [89.0 d](/filings/0001809104-24-000029.md) | [135 d](/filings/0001628280-26-011108.md) | [100](/filings/0001809104-25-000175.md) | [58.0 d](/filings/0001628280-25-037820.md) | [(24.0) d](/filings/0001628280-25-049916.md) | [118 d](/filings/0001628280-26-011108.md) | [73.0](/filings/0001628280-26-030596.md) | [86.0 d](/filings/0001628280-26-052636.md) | [77.0 d](/filings/0001628280-25-049916.md) | [124 d](/filings/0001628280-26-011108.md) | [79.0](/filings/0001628280-26-030596.md) | [73.0 d](/filings/0001628280-26-052636.md) | | Capital expenditure | $m | [36.0 d](/filings/0001809104-24-000029.md) | [26.0 d](/filings/0001628280-26-011108.md) | [31.0](/filings/0001809104-25-000175.md) | [36.0 d](/filings/0001628280-25-037820.md) | [28.0 d](/filings/0001628280-25-049916.md) | [26.0 d](/filings/0001628280-26-011108.md) | [29.0](/filings/0001628280-26-030596.md) | [28.0 d](/filings/0001628280-26-052636.md) | [28.0 d](/filings/0001628280-25-049916.md) | [25.0 d](/filings/0001628280-26-011108.md) | [26.0](/filings/0001628280-26-030596.md) | [25.0 d](/filings/0001628280-26-052636.md) | | Dividends paid | $m | not reported | not reported | [0.0](/filings/0001809104-25-000175.md) | [0.0 d](/filings/0001628280-25-037820.md) | [0.0 d](/filings/0001628280-25-049916.md) | [21.0 d](/filings/0001628280-26-011108.md) | [21.0](/filings/0001628280-26-030596.md) | [22.0 d](/filings/0001628280-26-052636.md) | [22.0 d](/filings/0001628280-25-049916.md) | [21.0 d](/filings/0001628280-26-011108.md) | [0.0](/filings/0001628280-26-030596.md) | [1.0 d](/filings/0001628280-26-052636.md) | | Share repurchases | $m | [26.0 d](/filings/0001809104-24-000029.md) | [0.0 d](/filings/0001628280-26-011108.md) | [0.0](/filings/0001809104-25-000175.md) | [80.0 d](/filings/0001628280-25-037820.md) | [75.0 d](/filings/0001628280-25-049916.md) | [12.0 d](/filings/0001628280-26-011108.md) | [20.0](/filings/0001628280-26-030596.md) | [20.0 d](/filings/0001628280-26-052636.md) | [25.0 d](/filings/0001628280-25-049916.md) | [0.0 d](/filings/0001628280-26-011108.md) | [0.0](/filings/0001628280-26-030596.md) | [0.0 d](/filings/0001628280-26-052636.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [458](/filings/0000950170-23-057516.md) | [476](/filings/0000950170-24-055909.md) | [490](/filings/0001809104-24-000015.md) | [493](/filings/0001809104-24-000029.md) | [542](/filings/0001809104-25-000175.md) | [547](/filings/0001628280-25-037820.md) | [536](/filings/0001628280-25-049916.md) | [532](/filings/0001628280-26-030596.md) | [26.4](/filings/0001628280-26-052636.md) | [527](/filings/0001628280-25-049916.md) | [525](/filings/0001628280-26-030596.md) | [26.4](/filings/0001628280-26-052636.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 446,790,011 at 2021-07-02, from the cover of the [10-Q filed 2021-08-16](/filings/0001104659-21-106452.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.